The cyclin-dependent kinase inhibitor p21 is essential for the beneficial effects of renal ischemic preconditioning on renal ischemia/reperfusion injury in mice

Kidney International

Volumn 85, Issue 4, 2014, Pages 871-879

  Nishioka, Satoshi ^a   Nakano, Daisuke ^a   Kitada, Kento ^a   Sofue, Tadashi ^a   Ohsaki, Hiroyuki ^b   Moriwaki, Kumiko ^a   Hara, Taiga ^a   Ohmori, Koji ^a   Kohno, Masakazu ^a   Nishiyama, Akira ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b EHIME PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

Author keywords

Cell cycle; Ischemia reperfusion; Ischemic preconditioning; p21

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA; PROTEIN P21; TRANSCRIPTION FACTOR NRF2; CYCLIN DEPENDENT KINASE INHIBITOR 1A; NFE2L2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; GENE EXPRESSION; ISCHEMIC PRECONDITIONING; KIDNEY ISCHEMIA; MALE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; WILD TYPE; ACUTE KIDNEY INJURY; ANIMAL; C57BL MOUSE; CELL CYCLE CHECKPOINT; KNOCKOUT MOUSE; METABOLISM; ACUTE KIDNEY FAILURE; ANIMAL CELL; HISTOPATHOLOGY; INJURY SEVERITY; KIDNEY FUNCTION; KIDNEY TUBULE CELL; PHYSICAL TOLERANCE; UPREGULATION;

ACUTE KIDNEY INJURY; ANIMALS; CELL CYCLE CHECKPOINTS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ISCHEMIC PRECONDITIONING; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 2; REPERFUSION INJURY;

EID: 84897954551     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.496     Document Type: Article

References (74)

1. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet 2005; 365: 417-430.
2. Srisawat N, Hoste EE, Kellum JA. Modern classification of acute kidney injury. Blood Purif 2010; 29: 300-307.
3. Lu JC, Coca SG, Patel UD et al. Searching for genes that matter in acute kidney injury: A systematic review. Clin J Am Soc Nephrol 2009; 4: 1020-1031.
4. Joannidis M, Metnitz PG. Epidemiology and natural history of acute renal failure in the ICU. Crit Care Clin 2005; 21: 239-249.
5. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 1996; 334: 1448-1460.
6. Mahfoudh-Boussaid A, Zaouali MA, Hadj-Ayed K et al. Ischemic preconditioning reduces endoplasmic reticulum stress and upregulates hypoxia inducible factor-1alpha in ischemic kidney: The role of nitric oxide. J Biomed Sci 2012; 19: 7.
7. Reutzel-Selke A, Pratschke J, Martins PN et al. Ischemic preconditioning produces systemic protective and adoptively transferable effects. Kidney Int 2008; 74: 622-630.
8. Wever KE, Menting TP, Rovers M et al. Ischemic preconditioning in the animal kidney, a systematic review and meta-Analysis. PLoS One 2012; 7: E32296.
9. Zimmerman RF, Ezeanuna PU, Kane JC et al. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney Int 2011; 80: 861-867.
10. Venugopal V, Laing CM, Ludman A et al. Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: A secondary analysis of 2 small randomized trials. Am J Kidney Dis 2010; 56: 1043-1049.
11. Grenz A, Osswald H, Eckle T et al. The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med 2008; 5: E137.
12. Joo JD, Kim M, D'Agati VD et al. Ischemic preconditioning provides both acute and delayed protection against renal ischemia and reperfusion injury in mice. J Am Soc Nephrol 2006; 17: 3115-3123.
13. Satake A, Takaoka M, Nishikawa M et al. Protective effect of 17betaestradiol on ischemic acute renal failure through the PI3K/Akt/eNOS pathway. Kidney Int 2008; 73: 308-317.
14. Leonard MO, Kieran NE, Howell K et al. Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury. FASEB J 2006; 20: 2624-2626.
15. Tomasevic G, Shamloo M, Israeli D et al. Activation of p53 and its target genes p21(WAF1/Cip1) and PAG608/Wig-1 in ischemic preconditioning. Brain Res Mol Brain Res 1999; 70: 304-313.
16. Tang Y, Pacary E, Freret T et al. Effect of hypoxic preconditioning on brain genomic response before and following ischemia in the adult mouse: Identification of potential neuroprotective candidates for stroke. Neurobiol Dis 2006; 21: 18-28.
17. Thiersch M, Raffelsberger W, Frigg R et al. Analysis of the retinal gene expression profile after hypoxic preconditioning identifies candidate genes for neuroprotection. BMC Genomics 2008; 9: 73.
18. Megyesi J, Andrade L, Vieira JM Jr. et al. Coordination of the cell cycle is an important determinant of the syndrome of acute renal failure. Am J Physiol Renal Physiol 2002; 283: F810-F816.
19. Megyesi J, Andrade L, Vieira JM Jr. et al. Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure. Kidney Int 2001; 60: 2164-2172.
20. Kfouri F, de Castro I, Testagrossa L et al. Role of p21 and oxidative stress on renal tubular resistance after acute ischaemic injury. Nephrol Dial Transplant 2010; 25: 1795-1803.
21. Ju Z, Choudhury AR, Rudolph KL. A dual role of p21 in stem cell aging. Ann N Y Acad Sci 2007; 1100: 333-344.
22. Kitada K, Nakano D, Hitomi H et al. High glucose-induced increase in p21 causes cellular senescence in proximal tubules of diabetic nephropathy. Hypertension 2011; 58: E39.
23. Lei B, Nakano D, Fan YY et al. Add-on aliskiren elicits stronger renoprotection than high-dose valsartan in type 2 diabetic KKAy mice that do not respond to low-dose valsartan. J Pharmacol Sci 2012; 119: 131-138.
24. Nakano D, Lei B, Kitada K et al. Aldosterone does not contribute to renal p21 expression during the development of angiotensin II-induced hypertension in mice. Am J Hypertens 2012; 25: 354-358.
25. Kitada K, Nakano D, Hitomi H et al. Aldosterone induces p21-regulated apoptosis via increased synthesis and secretion of tumour necrosis factoralpha in human proximal tubular cells. Clin Exp Pharmacol Physiol 2012; 39: 858-863.
26. Chkhotua AB, Abendroth D, Froeba G et al. Up-regulation of cell cycle regulatory genes after renal ischemia/reperfusion: Differential expression of p16(INK4a), p21(WAF1/CIP1) and p27(Kip1) cyclin-dependent kinase inhibitor genes depending on reperfusion time. Transpl Int 2006; 19: 72-77.
27. Li J, Ichikawa T, Jin Y et al. An essential role of Nrf2 in American ginsengmediated anti-oxidative actions in cardiomyocytes. J Ethnopharmacol 2010; 130: 222-230.
28. Mohammadzadeh M, Halabian R, Gharehbaghian A et al. Nrf-2 overexpression in mesenchymal stem cells reduces oxidative stressinduced apoptosis and cytotoxicity. Cell Stress Chaperones 2012; 17: 553-565.
29. Xu YQ, Zhang D, Jin T et al. Diurnal variation of hepatic antioxidant gene expression in mice. PLoS One 2012; 7: E44237.
30. Schachtele SJ, Hu S, Lokensgard JR. Modulation of experimental herpes encephalitis-Associated neurotoxicity through sulforaphane treatment. PLoS One 2012; 7: E36216.
31. Chen W, Sun Z, Wang XJ et al. Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. Mol Cell 2009; 34: 663-673.
32. Sakaue-Sawano A, Kurokawa H, Morimura T et al. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 2008; 132: 487-498.
33. Szeto HH, Liu S, Soong Y et al. Mitochondria-Targeted peptide accelerates ATP recovery and reduces ischemic kidney injury. J Am Soc Nephrol 2011; 22: 1041-1052.
34. Funk JA, Schnellmann RG. Persistent disruption of mitochondrial homeostasis after acute kidney injury. Am J Physiol Renal Physiol 2012; 302: F853-F864.
35. Hall AM, Rhodes GJ, Sandoval RM et al. In vivo multiphoton imaging of mitochondrial structure and function during acute kidney injury. Kidney Int 2013; 83: 72-83.
36. Megyesi J, Safirstein RL, Price PM. Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 1998; 101: 777-782.
37. Hochegger K, Koppelstaetter C, Tagwerker A et al. p21 and mTERT are novel markers for determining different ischemic time periods in renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 2007; 292: F762-F768.
38. Megyesi J, Udvarhelyi N, Safirstein RL et al. The p53-independent activation of transcription of p21 WAF1/CIP1/SDI1 after acute renal failure. Am J Physiol 1996; 271: F1211-F1216.
39. Garner E, Raj K. Protective mechanisms of p53-p21-pRb proteins against DNA damage-induced cell death. Cell Cycle 2008; 7: 277-282.
40. Roninson IB. Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): Association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 2002; 179: 1-14.
41. Price PM, Yu F, Kaldis P et al. Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2. J Am Soc Nephrol 2006; 17: 2434-2442.
42. Braun H, Schmidt BM, Raiss M et al. Cellular senescence limits regenerative capacity and allograft survival. J Am Soc Nephrol 2012; 23: 1467-1473.
43. Westhoff JH, Schildhorn C, Jacobi C et al. Telomere shortening reduces regenerative capacity after acute kidney injury. J Am Soc Nephrol 2010; 21: 327-336.
44. Chkhotua A, Shapira Z, Tovar A et al. Cellular senescence: A new marker of kidney function recovery after ischemic injury in rats. Transplant Proc 2001; 33: 2910-2915.
45. Leontieva OV, Natarajan V, Demidenko ZN et al. Hypoxia suppresses conversion from proliferative arrest to cellular senescence. Proc Natl Acad Sci USA 2012; 109: 13314-13318.
46. Cmielova J, Rezacova M. Protein and its function based on a subcellular localization. J Cell Biochem 2011; 112: 3502-3506.
47. Cazzalini O, Scovassi AI, Savio M et al. Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat Res 2010; 704: 12-20.
48. Asada M, Yamada T, Ichijo H et al. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J 1999; 18: 1223-1234.
49. Koster R, di Pietro A, Timmer-Bosscha H et al. Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer. J Clin Invest 2010; 120: 3594-3605.
50. Chen H, Li C, Huang J et al. CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21. J Clin Invest 2011; 121: 1549-1560.
51. Linas SL, Whittenburg D, Parsons PE et al. Ischemia increases neutrophil retention and worsens acute renal failure: Role of oxygen metabolites and ICAM 1. Kidney Int 1995; 48: 1584-1591.
52. Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 1984; 74: 1156-1164.
53. Nakajima A, Ueda K, Takaoka M et al. Opposite effects of pre-And postischemic treatments with nitric oxide donor on ischemia/reperfusioninduced renal injury. J Pharmacol Exp Ther 2006; 316: 1038-1046.
54. Noiri E, Nakao A, Uchida K et al. Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol 2001; 281: F948-F957.
55. Kasuno K, Nakamura H, Ono T et al. Protective roles of thioredoxin, a redox-regulating protein, in renal ischemia/reperfusion injury. Kidney Int 2003; 64: 1273-1282.
56. Kim J, Kim KY, Jang HS et al. Role of cytosolic NADP+-dependent isocitrate dehydrogenase in ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol 2009; 296: F622-F633.
57. Hall AM, Crawford C, Unwin RJ et al. Multiphoton imaging of the functioning kidney. J Am Soc Nephrol 2011; 22: 1297-1304.
58. Nowak G, Bakajsova D, Samarel AM. Protein kinase C-epsilon activation induces mitochondrial dysfunction and fragmentation in renal proximal tubules. Am J Physiol Renal Physiol 2011; 301: F197-F208.
59. Lu YZ, Wu CC, Huang YC et al. Neutrophil priming by hypoxic preconditioning protects against epithelial barrier damage and enteric bacterial translocation in intestinal ischemia/reperfusion. Lab Invest 2012; 92: 783-796.
60. Fan YY, Kohno M, Hitomi H et al. Aldosterone/mineralocorticoid receptor stimulation induces cellular senescence in the kidney. Endocrinology 2011; 152: 680-688.
61. Patni H, Mathew JT, Luan L et al. Aldosterone promotes proximal tubular cell apoptosis: Role of oxidative stress. Am J Physiol Renal Physiol 2007; 293: F1065-F1071.
62. Liang HL, Sedlic F, Bosnjak Z et al. SOD1 and MitoTEMPO partially prevent mitochondrial permeability transition pore opening, necrosis, and mitochondrial apoptosis after ATP depletion recovery. Free Radic Biol Med 2010; 49: 1550-1560.
63. Wu HH, Hsiao TY, Chien CT et al. Ischemic conditioning by short periods of reperfusion attenuates renal ischemia/reperfusion induced apoptosis and autophagy in the rat. J Biomed Sci 2009; 16: 19.
64. Chen H, Xing B, Liu X et al. Similarities between ozone oxidative preconditioning and ischemic preconditioning in renal ischemia/reperfusion injury. Arch Med Res 2008; 39: 169-178.
65. Kirpatovskii VI, Kazachenko AV, Plotnikov EY et al. Effects of ischemic and hypoxic preconditioning on the state of mitochondria and function of ischemic kidneys. Bull Exp Biol Med 2007; 143: 105-109.
66. Plotnikov EY, Kazachenko AV, Vyssokikh MY et al. The role of mitochondria in oxidative and nitrosative stress during ischemia/reperfusion in the rat kidney. Kidney Int 2007; 72: 1493-1502.
67. Kim J, Jang HS, Park KM. Reactive oxygen species generated by renal ischemia and reperfusion trigger protection against subsequent renal ischemia and reperfusion injury in mice. Am J Physiol Renal Physiol 2010; 298: F158-F166.
68. Trakala M, Arias CF, Garcia MI et al. Regulation of macrophage activation and septic shock susceptibility via p21(WAF1/CIP1). Eur J Immunol 2009; 39: 810-819.
69. Merched AJ, Chan L. Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis. Circulation 2004; 110: 3830-3841.
70. Sutton TA, Hato T, Mai E et al. p53 Is renoprotective after ischemic kidney injury by reducing inflammation. J Am Soc Nephrol 2012; 24: 113-124.
71. Yamamoto S, Watanabe B, Hiratake J et al. Preventive effect of GGsTop, a novel and selective gamma-glutamyl transpeptidase inhibitor, on ischemia/reperfusion-induced renal injury in rats. J Pharmacol Exp Ther 2011; 339: 945-951.
72. Yamasowa H, Shimizu S, Inoue T et al. Endothelial nitric oxide contributes to the renal protective effects of ischemic preconditioning. J Pharmacol Exp Ther 2005; 312: 153-159.
73. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991; 108: 193-199.
74. Nakano D, Kobori H, Burford JL et al. Multiphoton imaging of the glomerular permeability of angiotensinogen. J Am Soc Nephrol 2012; 23: 1847-1856.